-
Je něco špatně v tomto záznamu ?
Impact of paraoxon followed by acetylcholinesterase reactivator HI-6 on gastric myoelectric activity in experimental pigs
J. Bures, J. Kvetina, M. Pavlik, M. Kunes, M. Kopacova, S. Rejchrt, D. Jun, M. Hrabinova, K. Kuca, I. Tachecí,
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT14270
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
24362097
Knihovny.cz E-zdroje
- MeSH
- elektromyografie MeSH
- injekce intramuskulární MeSH
- modely u zvířat MeSH
- oximy aplikace a dávkování MeSH
- paraoxon aplikace a dávkování MeSH
- prasata MeSH
- pyridinové sloučeniny aplikace a dávkování MeSH
- reaktivátory cholinesterasy aplikace a dávkování MeSH
- srdeční frekvence účinky léků fyziologie MeSH
- žaludek účinky léků fyziologie MeSH
- zvířata MeSH
- Check Tag
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: Organophosphorus compounds represent nerve agents, pesticides and several industrial compounds. Treatment after exposure to organophosphates involves the use of parasympatolytics, acetylcholinesterase (AChE) reactivators/modulators and anticonvulsive drugs. Wider clinical use of several AChE reactivators/modulators might be limited because of possible side effects, including gastrointestinal toxicity. In this study we evaluated the effect of paraoxon and an AChE reactivator (HI-6) on the gastric myoelectric activity in experimental pigs. METHODS: Six female experimental pigs (mean weight 33 kg) entered the study. Intramuscular paraoxon (1.5 g) was administrated after the baseline gastric electrogastrography (EGG) recording, followed by HI-6 dimethansulphonate (1.5 g i.m.) 10 min. later. A further ten 15-minute-interval EGG recordings were performed. Running spectral analysis was used for the elemental evaluation of the EGG. The results were expressed as dominant frequency of slow waves at all intervals of EGG recordings. EGG power analysis was performed in all animals. RESULTS: Paraoxon induced a non-significant decrease of dominant frequency (2.8±0.6 vs. 2.6±0.5 cycles per min.; p=0.092). Subsequent administration of HI-6 normalised dominant frequency to basal values and increased it significantly within the subsequent 30 minutes (3.0±0.4; p<0.001). Paraoxon administration did not influence the power (within a 10-minute exposure). However, the amplitudes increased significantly 90 minutes after administration of HI-6 (819±109 vs. 5054±732 μV2; p<0.001). CONCLUSIONS: AChE reactivator HI-6 blocked the gastric effect of paraoxon significantly. Subsequent myoelectric changes in the dominant frequency and power were executed by HI-6. The effect of paraoxon was non-significant.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14063799
- 003
- CZ-PrNML
- 005
- 20191118141503.0
- 007
- ta
- 008
- 140704s2013 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)24362097
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Bureš, Jan, $u 2nd Department of Internal Medicine - Gastroenterology, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic. bures@lfhk.cuni.cz. $d 1954- $7 nlk19990073060
- 245 10
- $a Impact of paraoxon followed by acetylcholinesterase reactivator HI-6 on gastric myoelectric activity in experimental pigs / $c J. Bures, J. Kvetina, M. Pavlik, M. Kunes, M. Kopacova, S. Rejchrt, D. Jun, M. Hrabinova, K. Kuca, I. Tachecí,
- 520 9_
- $a OBJECTIVES: Organophosphorus compounds represent nerve agents, pesticides and several industrial compounds. Treatment after exposure to organophosphates involves the use of parasympatolytics, acetylcholinesterase (AChE) reactivators/modulators and anticonvulsive drugs. Wider clinical use of several AChE reactivators/modulators might be limited because of possible side effects, including gastrointestinal toxicity. In this study we evaluated the effect of paraoxon and an AChE reactivator (HI-6) on the gastric myoelectric activity in experimental pigs. METHODS: Six female experimental pigs (mean weight 33 kg) entered the study. Intramuscular paraoxon (1.5 g) was administrated after the baseline gastric electrogastrography (EGG) recording, followed by HI-6 dimethansulphonate (1.5 g i.m.) 10 min. later. A further ten 15-minute-interval EGG recordings were performed. Running spectral analysis was used for the elemental evaluation of the EGG. The results were expressed as dominant frequency of slow waves at all intervals of EGG recordings. EGG power analysis was performed in all animals. RESULTS: Paraoxon induced a non-significant decrease of dominant frequency (2.8±0.6 vs. 2.6±0.5 cycles per min.; p=0.092). Subsequent administration of HI-6 normalised dominant frequency to basal values and increased it significantly within the subsequent 30 minutes (3.0±0.4; p<0.001). Paraoxon administration did not influence the power (within a 10-minute exposure). However, the amplitudes increased significantly 90 minutes after administration of HI-6 (819±109 vs. 5054±732 μV2; p<0.001). CONCLUSIONS: AChE reactivator HI-6 blocked the gastric effect of paraoxon significantly. Subsequent myoelectric changes in the dominant frequency and power were executed by HI-6. The effect of paraoxon was non-significant.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a reaktivátory cholinesterasy $x aplikace a dávkování $7 D002801
- 650 _2
- $a elektromyografie $7 D004576
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční frekvence $x účinky léků $x fyziologie $7 D006339
- 650 _2
- $a injekce intramuskulární $7 D007273
- 650 _2
- $a modely u zvířat $7 D023421
- 650 _2
- $a oximy $x aplikace a dávkování $7 D010091
- 650 _2
- $a paraoxon $x aplikace a dávkování $7 D010261
- 650 _2
- $a pyridinové sloučeniny $x aplikace a dávkování $7 D011726
- 650 _2
- $a žaludek $x účinky léků $x fyziologie $7 D013270
- 650 _2
- $a prasata $7 D013552
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Květina, Jaroslav, $u 2nd Department of Internal Medicine - Gastroenterology, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic. $d 1930- $7 jk01071205
- 700 1_
- $a Pavlík, Michal $u Department of Teaching Support, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic. $7 _AN085450
- 700 1_
- $a Kuneš, Martin $u Biomedical Research Center, University Hospital, Hradec Králové, Czech Republic. $7 xx0081968
- 700 1_
- $a Kopáčová, Marcela, $u 2nd Department of Internal Medicine - Gastroenterology, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic. $d 1959- $7 xx0032944
- 700 1_
- $a Rejchrt, Stanislav, $u 2nd Department of Internal Medicine - Gastroenterology, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic. $d 1963- $7 mzk2005306779
- 700 1_
- $a Jun, Daniel, $u Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic. $d 1976- $7 xx0040498
- 700 1_
- $a Hrabinová, Martina $u Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic. $7 xx0118798
- 700 1_
- $a Kuča, Kamil, $u Biomedical Research Center, University Hospital, Hradec Králové, Czech Republic. $d 1978- $7 xx0041831
- 700 1_
- $a Tachecí, Ilja $u 2nd Department of Internal Medicine - Gastroenterology, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic. $7 xx0077741
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 34 Suppl 2, č. - (2013), s. 79-83
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24362097 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20191118141744 $b ABA008
- 999 __
- $a ok $b bmc $g 1031283 $s 862531
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 34 Suppl 2 $c - $d 79-83 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- GRA __
- $a NT14270 $p MZ0
- LZP __
- $a Pubmed-20140704